微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -5.6% | -5.07% | -54.27% | 48/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -3.63% | 40.2% | -33.46% | 47/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -2.72% | -55.43% | 77.76% | 46/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -12.23% | 47.38% | -129.46% | 45/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | -5.33% | 68.01% | 12.19% | 47/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | -6.07% | 46.85% | -246.86% | 47/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -1.75% | 79.02% | 92.47% | 45/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -23.24% | -72.28% | -39.5% | 44/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | -16.66% | -60.04% | -45.88% | 45/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | -11.42% | -120.46% | -36.93% | 47/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | -8.34% | -153.5% | 38.18% | 42/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -13.49% | -3.53% | -29.59% | 44/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | -10.41% | 1.7% | -100.97% | 36/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | -5.18% | 29.62% | -57.45% | 45/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | -3.29% | 15.64% | 74.75% | 31/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -13.03% | -50.12% | -23.04% | 47/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | -10.59% | -2841.67% | -43.89% | 31/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -7.36% | -3988.89% | -88.72% | 35/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -3.9% | -880% | 55.07% | 28/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | -8.68% | -1089.04% | -2311.11% | 42/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | -0.36% | -100.77% | -100% | 25/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | -0.18% | -156.25% | -136% | 27/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 0.5% | -7.41% | 168.49% | 22/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | -0.73% | -112.9% | -101.56% | 39/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 46.66% | 813.11% | 14481.25% | 1/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 0.32% | -91.04% | -40.74% | 28/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 0.54% | -71.28% | -90.46% | 23/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 5.66% | -10.58% | 10.76% | 25/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 5.11% | -10.66% | 43.14% | 18/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 3.57% | -14.18% | 89.89% | 16/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 1.88% | 16.77% | -70.3% | 12/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 6.33% | -22.71% | 10.66% | 23/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 5.72% | -18.52% | 37.5% | 10/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 4.16% | -33.44% | 158.39% | 13/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 1.61% | -72.9% | -80.34% | 10/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 8.19% | -52.49% | 16.67% | 20/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 7.02% | -51.39% | 12.32% | 10/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 6.25% | -36.74% | 5.22% | 6/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 5.94% | 17.86% | -65.55% | 1/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |